Article Details
Retrieved on: 2022-07-14 13:20:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The Goldman Sachs Group set a GBX 6,950 ($82.66) target price on shares of AstraZeneca in a research note on Friday, April 29th. Credit Suisse Group ...
Article found on: www.defenseworld.net
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here